Key indicators
4,3billion tenge
savings as a result of the purchase
98
long-term agreements with DM’s
6
memoranda with pharmaceutical companies in 2023
3
long-term contracts for contract manufacturing with BIGPHARMA
525
units of medical equipment purchased in 2023
78%
purchase of drugs and medical supplies from DM’s
1571
types of medicines and medical supplies were purchased in 2023 for the amount of 449.5 billion tenge
148
types of medicines and medical supplies were purchased through direct contracts in 2023
13
types of medicines and medical supplies were purchased through international organizations in 2023
616
items of medicines and medical supplies purchased through a two-stage tender in 2023
Services
The head's blog
Yerken Isakhanuly Zhakatay
Chairman of the Management Board

Dear blog visitors!

I am glad to welcome you to the blog pages. The blog platform is another unique opportunity for communication, which is provided to us by modern high technologies.

I hope that this interactive resource can become a good platform for a broad discussion of issues in the pharmaceutical industry of the Republic of Kazakhstan.

I am confident that the blog will allow us to establish new ways of dialogue with such a wide audience as the Internet community.

We will try to be as open as possible to constructive dialogue and not to leave without attention any question you ask, related to the competence and scope of activities of SK-Pharmaceuticals LLP.

I will be grateful to you for your attention and suggestions!

Write